Evaluation of heart rate variability in patients with different forms of pulmonary hypertension
https://doi.org/10.26442/2075082X.2021.3.201066
Abstract
Pulmonary hypertension (PH) is a severe pathology of the cardiovascular system with extremely poor prognosis, if unreated. Early diagnosis of PH is difficult, due to the absence pathognomonic symptoms, and at the initial stage the disease may be asymptomatic. An increase in pulmonary vascular resistance and pressure in the pulmonary artery cause severe dysfunction of the right ventricle, which affects the functional status of patients. The assessment of heart rate variability (HRV) parameters is used to predict the increased risk of sudden death in various diseases of the cardiovascular system and the functional status of the body. HRV is mainly regulated by the sympathetic and parasympathetic divisions of the autonomic nervous system. It is noted that pulmonary arterial hypertension is associated with increasing of sympathetic activity. The review, based on the analysis of the pathophysiological mechanisms of pulmonary arterial hypertension and chronic thromboembolic PH, presents the results of studies assessing the time and spectral parameters of HRV in patients with PH of various etiologies.
About the Authors
N. Kh. Qurbonbekova
National Medical Research Center of Cardiology
Russian Federation
Russian Federation
A. M. Kasparova
National Medical Research Center of Cardiology
Russian Federation
Russian Federation
E. Sh. Kozhemyakina
National Medical Research Center of Cardiology
Russian Federation
Russian Federation
A. V. Sobolev
National Medical Research Center of Cardiology
Russian Federation
Russian Federation
T. V. Martynyuk
National Medical Research Center of Cardiology; Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
References
1. Chazova IE, Martyniuk TV, Valieva SZ, et al. Evraziiskie klinicheskie rekomendatsii po diagnostike i lecheniiu legochnoi gipertonii. Evraziiskii kardiologichrskii zhurnal. 2020;1:78-122 (in Russian). doi: 10.24411/2076-4766-2020-10002
2. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J. 2015;46(4):903-75.
3. Humbert M, Farber HW, Ghofrani HA, et al. Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Eur Respir J. 20195;53(6):1802004. doi: 10.1183/13993003.02004-2018; PMID: 30923187; PMCID: PMC6551213.
4. Chazova IE, Martynyuk TV. Pulmonary hypertension. Moscow: Practice, 2015 (in Russian).
5. Martynyuk TV. Pulmonary hypertension: diagnosis and treatment. Moscow, 2018. Ser. Library of the Federal State Budgetary Institution “National Medical Research Center of Cardiology” of the Ministry of Health of Russia (in Russian).
6. Lang IM, Dorfmüller P, Vonk Noordegraaf A. The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension. Ann Am Thorac Soc. 2016;13(Suppl.3):S215-21.
7. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1990;81:1735-43.
8. Pepke-Zaba J, Jansa P, Kim H, et al. Chronic Thromboembolic pulmonary hypertension: role of medical therapy. Eur Respir J. 2013;41:985-90. doi: 10.1183/09031936.00201612
9. Chazova IE, Martynyuk TV, Filippov EV, et al. Clinical practice guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension. (Part 2). Terapevticheskii Arkhiv (Ter. Arkh). 2016;88(10):63-74 (in Russian).
10. Jenkins D, Madani M, Fabel E, et al. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143)26:160111. doi: 10.1183/16000617.011-2016; PMID: 28298388
11. Danilov NM, Matchin YuG, Martynyuk TV. Balloon angioplasty of pulmonary arteries in inoperable chronic thromboembolic pulmonary hypertension. Consilium Medicum. 2016;18(5):59-61 (in Russian).
12. Baevskii RM. Analiz variabel'nosti serdechnogo ritma pri ispol'zovanii razlichnykh elektrokardiograficheskikh sistem (metodicheskie rekomendatsii). Vestnik aritmologii. 2001;24:66-85 (in Russian).
13. Baevsky RM, Kirilov OI, Kletskin SZ. Mathematical analysis of changes in heart rate during stress. Moscow: Nauka, 1984 (in Russian).
14. Standarts of measurments, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17:354-81.
15. Task Force report. Heart rate variability: physiological interpretation and clinical use. Circulation. 1996;93:1043-65. doi: 10.1161/01.CIR.93.5.1043
16. Sobolev AV. Methods for analyzing heart rate variability over long periods of time. Moscow: Medpraktika, 2009 (in Russian).
17. Sobolev AV. Analysis of sinus rhythm variability. In: Functional diagnostics: national guidelines. Ed. NF Beresten, VA Sandrikov, SI Fedorov. Moscow: GEOTAR-Media, 2019. Ser. Library of the FSBI “National Medical Research Center of Cardiology” of the Ministry of Health of Russia. Ch. 2. Clinical electrocardiology (in Russian).
18. Khaiutin VM, Lukoshkova EV. Kolebaniia chastoty serdtsebienii: Spektral'nyi analiz. Vestnik aritmologii. 2002;26:10-21 (in Russian).
19. Ryabykina GV, Sobolev AV. Holter and bifunctional monitoring of ECG and blood pressure. Ed. 2nd. Moscow: MEDPRAKTIKA-M, 2016 (in Russian).
20. Boitsov SA, Belozertseva IV, Kuchmin AN, et al. Vozrastnye osobennosti izmeneniia pokazatelei variabel'nosti serdechnogo ritma u prakticheski zdorovykh lits. Vestnik aritmologii. 2002;26:57-60 (in Russian).
21. Poteshkina NG, Tuev AV, Grigoriadi NE. Vremennoi analiz variabel'nosti serdechnogo ritma u bol'nykh arterial'noi gipertenziei. Vestnik aritmologii. 2002;30:54-7 (in Russian).
22. Kakhramanova SM, Bakhshaliev AB, Nasrullaev NS. Variabel'nost' serdechnogo ritma pri gipertonicheskoi bolezni. Kardiovaskuliarnaia terapiia i profilaktika. 2010;9(8):96-101 (in Russian).
23. Mortara A, La Rovere M, Pinna G, et al. Nonselective betaadrenergic blocking agent,carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure. JACC. 2000;1:1612-8.
24. Рябыкина Г.В., Чазова И.Е., Мычка В.Б., и др. Динамика вариабельности ритма сердца при лечении артериальной гипертонии. Кардиология. 2008;7:18-24 [Riabykina GV, Chazova IE, Mychka VB, et al. Dinamika variabel'nosti ritma serdtsa pri lechenii arterial'noi gipertonii. Kardiologiia. 2008;7:18-24 (in Russian)].
25. Hamada T, Watanabe M, Kaneda T. Evaluation of changes of sympathetic nerve activity and heart rate in essential hypertension patients induced by amlodipine and nifedipine. J Hypertens. 1998;16(1):111-8.
26. McGowan CL, Swiston JS, Notarius CF, et al. Discordance between microneurographic and heart rate spectral indices of sympathetic activity in pulmonary arterial hypertension. Heart. 2009;95:754-8.
27. Velez-Roa S, Giarka A, Najem B, et al. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004;110:1308-12.
28. Wensel R, Jilek C, Dorr M, et al. Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension. Eur Respir J. 2009;34:895-901.
29. Akgul F, Batyraliev TA, Fettser DV, et al. Decreased heart rate variability in sickle cell anemia as effect off pulmonary arterial hypertension. Kardiologiia. 2019;59(4):39-44.
30. Carvalho CG, Bresler R, Zhi YX, et al. Heart rate variability in pulmonary hypertension with and without sleep apnea. Heliyon. 2019;5:1-8.
31. Yi HT, Hsieh YC, Wu TJ, et al. Heart rate variability parameters and ventricular arrhythmia correlate with pulmonary arterial pressure in adult patients with idiopathic pulmonary arterial hypertension. Heart Lung. 2014;43:534-40.
32. Irodova NL. Klinicheskoe znachenie narushenii v simpatoadrenalovoi sisteme i beta-2 adrenoretseptor-zavisimoi adenilattsiklaznoi sisteme limfotsitov u bol'nykh s pervichnoi legochnoi gipertenziei i vliianie na nikh dilatrendom (karvedilolom): avtoref. dis. … kand. med. nauk. Moscow, 2002 (in Russian).
33. Fauchier L, Babuty D, Melin A, et al. Herat rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances. Eur J Heart Fail. 2004;6(2):181-5.
34. Witte C, Meyer zur Heide Genannt Meyer-Arend JU, Andrie R, et al. Heart rate variability and arrhythmic Burden in Pulmonary Hypertension. Adv Exp Med Biol. 2016;25:9-22.
35. Qian Z, Fan A, Dawa, et al. Retrospective cohort analysis of heart rate variability in patent with high altitude pulmonary hypertension in Tibet. Clin Cardiol. 2020;43:298-304. doi: 10.1002/clc.2312
36. Riabykina GV, Sobolev AV, Arkhipova OA, et al. Kholterovskoe monitorirovanie EKG pri obsledovanii bol'nykh idiopaticheskoi legochnoi gipertenziei. Ch. 1. Osobennosti serdechnogo ritma u bol'nykh idiopaticheskoi legochnoi arterial'noi gipertenziei. Terapevt. 2013;4:4-14 (in Russian).
37. Sobolev AV. Novyi podkhod k otsenke individual'noi sutochnoi variabel'nosti ritma serdtsa u patsienta. Kardiologiia. 2003;8:16-21 (in Russian).
38. Sobolev AV, Talabanov PG, Ryabykina GV, et al. New approaches to the analysis of the daily variability of sinus rhythm when assessing the antihypertensive effect of various drugs. Systemic Hypertension. 2019;16(4):70-9 (in Russian).
39. Sobolev AV, Riabykina GV, Kozhemiakina ESh. Novyi metod analiza sutochnoi variabel'nosti sinusovogo ritma na dlitel'nykh promezhutkakh vremeni, uchityvaiushchii nalichie na ritmogrammy dvoinykh izlomov. Sovremnnaia funktsional'naia diagnostika. 2017;1:22-6 (in Russian).
40. Sobolev AV, Ryabykina GV, Kozhemyakina ESh. Specificity of the influence of double breaks in the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension. Systemic Hypertension. 2021;18(1):43-9 (in Russian).
Review
For citations:
Qurbonbekova N.Kh., Kasparova A.M., Kozhemyakina E.Sh., Sobolev A.V., Martynyuk T.V. Evaluation of heart rate variability in patients with different forms of pulmonary hypertension. Systemic Hypertension. 2021;18(3):147-152. (In Russ.) https://doi.org/10.26442/2075082X.2021.3.201066
Views:
626
JATS XML
Email this article 